Suppr超能文献

在撒哈拉以南非洲的八个国家中,开始接受抗逆转录病毒治疗的人群中,CD4+细胞计数低的方案层面和环境层面决定因素。

Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.

机构信息

International Center for AIDS Care and Treatment Programs, Columbia University Mailman School of Public Health, New York, New York, USA.

出版信息

AIDS. 2011 Jul 31;25(12):1523-33. doi: 10.1097/QAD.0b013e32834811b2.

Abstract

OBJECTIVE

In sub-Saharan Africa, many patients initiate antiretroviral therapy (ART) at CD4 cell counts much lower than those recommended in national guidelines. We examined program-level and contextual-level factors associated with low median CD4 cell count at ART initiation in populations initiating ART.

DESIGN

Multilevel analysis of aggregate and program-level service delivery data.

METHODS

We examined data on 1690 cohorts of patients initiating ART during 2004-2008 in eight sub-Saharan African countries. Cohorts with median CD4 less than 111 cells/μl (the lowest quartile) were classified as having low median CD4 cell count at ART initiation. Cohort information was combined with time-updated program-level data and subnational contextual-level data, and analyzed using multilevel models.

RESULTS

The 1690 cohorts had median CD4 cell count of 136 cells/μl and included 121,504 patients initiating ART at 267 clinics. Program-level factors associated with low cohort median CD4 cell count included urban setting [adjusted odds ratio (AOR) 2.1; 95% confidence interval (CI) 1.3-3.3], lower provider-to-patient ratio (AOR 2.2; 95% CI 1.3-4.0), no PMTCT program (AOR 3.6; 95% CI 1.0-12.8), outreach services for ART patients only vs. both pre-ART and ART patients (AOR 2.4; 95% CI 1.5-3.9), fewer vs. more adherence support services (AOR 1.6; 95% CI 1.0-2.5), and smaller cohort size (AOR 2.5; 95% CI 1.4-4.5). Contextual-level factors associated with low cohort median CD4 cell count included initiating ART in areas where a lower proportion of the population heard of AIDS, tested for HIV recently, and a higher proportion believed 'limiting themselves to one HIV-uninfected sexual partner reduces HIV risk'.

CONCLUSION

Determinants of CD4 cell count at ART initiation in populations initiating ART operate at multiple levels. Structural interventions targeting points upstream from ART initiation along the continuum from infection to diagnosis to care engagement are needed.

摘要

目的

在撒哈拉以南非洲地区,许多患者在开始接受抗逆转录病毒治疗(ART)时的 CD4 细胞计数远低于国家指南建议的水平。本研究旨在探讨与人群开始接受 ART 时 CD4 细胞计数较低相关的项目层面和环境层面的因素。

设计

对聚集和项目层面服务提供数据进行的多水平分析。

方法

我们对 2004-2008 年间在撒哈拉以南非洲 8 个国家的 1690 个开始接受 ART 的患者队列的数据进行了研究。将 CD4 中位数<111 个细胞/μl(最低四分位数)的队列归类为开始接受 ART 时 CD4 细胞计数较低的队列。将队列信息与时间更新的项目层面数据和次国家级环境层面数据相结合,并使用多水平模型进行分析。

结果

这 1690 个队列的 CD4 细胞中位数为 136 个细胞/μl,包括 267 个诊所中 121504 名开始接受 ART 的患者。与队列 CD4 中位数较低相关的项目层面因素包括城市环境[校正比值比(AOR)2.1;95%置信区间(CI)1.3-3.3]、提供者与患者比例较低(AOR 2.2;95%CI 1.3-4.0)、无母婴传播预防项目(AOR 3.6;95%CI 1.0-12.8)、仅为接受 ART 的患者提供外展服务与同时为接受 ART 前和接受 ART 的患者提供服务(AOR 2.4;95%CI 1.5-3.9)、接受 ART 的患者接受的遵医用药支持服务较少(AOR 1.6;95%CI 1.0-2.5)以及队列规模较小(AOR 2.5;95%CI 1.4-4.5)。与队列 CD4 中位数较低相关的环境层面因素包括在人口中听说过艾滋病的比例较低、最近接受过 HIV 检测的比例较低以及相信“限制自己与一个 HIV 阴性性伴侣发生性关系可降低 HIV 风险”的比例较高的地区开始接受 ART。

结论

开始接受 ART 的人群中 CD4 细胞计数的决定因素在多个层面起作用。需要针对从感染到诊断再到治疗参与的连续过程中 ART 开始之前的各个点,采取结构性干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2dd/3422866/1919f4c69b64/nihms391503f1.jpg

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验